Gentex Q4 Earnings Miss Expectations, Sales Decline Y/Y

03.02.25 15:07 Uhr

Werte in diesem Artikel
Aktien

25,00 EUR -2,20 EUR -8,09%

Indizes

19.392,0 PKT -235,5 PKT -1,20%

1.854,4 PKT -8,4 PKT -0,45%

Gentex Corporation’s GNTX fourth-quarter 2024 earnings per share (EPS) of 39 cents missed the Zacks Consensus Estimate of 49 cents and decreased 22% year over year.This Zeeland-based automotive products supplier reported net sales of $542 million, which missed the Zacks Consensus Estimate of $602 million and fell 8% from the year-ago period. The company recorded a gross margin of 32.5%, reflecting a decline of 200 basis points from the fourth quarter of 2023 due to lower-than-expected sales, an unfavorable product mix and difficulty in spreading overhead costs efficiently.See the Zacks Earnings Calendar to stay ahead of market-making news.Gentex Corporation Price, Consensus and EPS Surprise Gentex Corporation price-consensus-eps-surprise-chart | Gentex Corporation QuoteSegmental PerformanceThe Automotive segment’s net sales — contributing the most to Gentex’s revenues — totaled $531.3 million in the fourth quarter, lower than the $578.7 million reported in the year-ago quarter and missed our estimate of $585.9 million. In the reported quarter, auto-dimming mirror shipments in the North American market decreased 10% to 3,438,000 units. Shipments fell 14% year over year in the international markets to 7,339,000 units. Total shipments declined 13% to 10,777,000 units.Other net sales, which include dimmable aircraft windows, fire protection products and medical products decreased from the year-ago quarter’s $10.5 million to $10.3 million and lagged our estimate of $13.5 million. Fire protection sales increased 5% year over year, while dimmable aircraft window sales decreased 23% year over year. Medical product sales totaled $0.6 million in the fourth quarter of 2024.Financial TidbitsTotal operating expenses rose 22% year over year to $86.5 million in fourth-quarter 2024. Engineering and R&D expenses increased to $47.06 million from $41.53 million. SG&A expenses rose to $30.53 million from $29.06 million recorded in the corresponding quarter of 2023.GNTX paid a dividend of 12 cents per share in the quarter. It repurchased 603,396 shares of its common stock at an average price of $30.54 per share. As of Dec. 31, 2024, the company had nearly 9.4 million shares remaining for buyback, per its previously announced share repurchase plan. Gentex had cash and cash equivalents of about $233.3 million as of Dec. 31, 2024.GNTX Provides 2025 GuidanceGentex expects 2025 net sales in the range of $2.40-$2.45 billion compared with $2.31 billion recorded in 2024. The gross margin is projected in the band of 33.5-34.5% compared with the 33.3% reported in 2024. Capital expenditure is anticipated between $125 million and $150 million, while operating expenses are estimated in the band of $310-$320 million.Zacks Rank & Key PicksGNTX carries a Zacks Rank #3 (Hold) at present.Some better-ranked stocks in the auto space are Geely Automobile Holdings Limited GELYY, Yamaha Motor Co., Ltd. YMHAY and Allison Transmission Holdings, Inc. ALSN. While GELYY sports a Zacks Rank #1 (Strong Buy), YMHAY and ALSN carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for GELYY’s fiscal 2025 sales and earnings suggests year-over-year growth of 66.62% and 149.31%, respectively. EPS estimates for fiscal 2025 and 2026 have improved by 15 cents and 38 cents, respectively, in the past 30 days. The Zacks Consensus Estimate for YMHAY’s 2025 sales and earnings suggests year-over-year growth of 8.69%and 19.07%, respectively. EPS estimates for 2025 have improved by a penny in the past 60 days.The Zacks Consensus Estimate for ALSN’s 2025 sales and earnings suggests year-over-year growth of 6.67% and 11.40%, respectively. EPS estimates for 2025 have improved 3 cents in the past 30 days.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Allison Transmission Holdings, Inc. (ALSN): Free Stock Analysis Report Gentex Corporation (GNTX): Free Stock Analysis Report Geely Automobile Holdings Ltd. (GELYY): Free Stock Analysis Report Yamaha Motor Co., Ltd. (YMHAY): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Gentex

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Gentex

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Gentex Corp.

Wer­bung

Analysen zu Gentex Corp.

DatumRatingAnalyst
29.01.2018Gentex BuyB. Riley FBR, Inc.
23.01.2018Gentex NeutralRobert W. Baird & Co. Incorporated
24.08.2017Gentex OutperformRobert W. Baird & Co. Incorporated
23.12.2016Gentex OutperformBMO Capital Markets
21.10.2016Gentex OutperformFBR & Co.
DatumRatingAnalyst
29.01.2018Gentex BuyB. Riley FBR, Inc.
24.08.2017Gentex OutperformRobert W. Baird & Co. Incorporated
23.12.2016Gentex OutperformBMO Capital Markets
21.10.2016Gentex OutperformFBR & Co.
23.04.2009Gentex outperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
23.01.2018Gentex NeutralRobert W. Baird & Co. Incorporated
27.01.2016Gentex NeutralRobert W. Baird & Co. Incorporated
19.06.2009Gentex neutralRobert W. Baird & Co. Incorporated
18.06.2009Gentex neutralRobert W. Baird & Co. Incorporated
24.10.2006Gentex neutralUBS
DatumRatingAnalyst
13.12.2006Gentex sellCitigroup
05.12.2006Update Gentex Corp.: ReduceUBS
22.07.2005Update Gentex Corp.: ReduceCalyon Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Gentex Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"